Novo Nordisk said an older version of its weight-loss drug semaglutide failed to meet its main goal in late-stage trials ...

Novo's upcoming Alzheimer's trial results will test whether Rybelsus can slow cognitive decline and reshape treatment ...

Shares of Biogen rose 3% following news of Novo's Alzheimer's trial failure. Biogen and partner Eisai's Leqembi and rival Eli ...

Studies from Novo Nordisk due early next month will give the strongest indication yet of whether blockbuster GLP-1 drugs - a ...

Such conversations are becoming increasingly common as demand for weight-loss drugs explodes in urban India - a country with the world's second-largest number of overweight adults and more than 77 ...

These drugs must be started only after a full medical evaluation, used strictly under medical supervision and avoided ...

Weight loss medications may help older adults lose and manage their weight. The drugs may work by decreasing your appetite or helping you feel fuller for longer. For best results, combine weight loss ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

The oral version of Rybelsus failed to meet its primary goal in two late-stage clinical trials, which aimed to evaluate its ...

Novo won the U.S. Food and Drug Administration's approval in 2024 to use Wegovy to reduce the risk of cardiovascular death, ...

Robbie Williams' concerns over weight-loss injections potentially harming his eyesight have sparked widespread worry. While ...